Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumacaftor and Ivacaftor in Cystic Fibrosis (F508del)
NCT01225211Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Oct 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of lumacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Oct 2010; status: completed.
02
Drugs
lumacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01225211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225211.